COMMUNIQUÉS West-GlobeNewswire

Twentyeight Health Partners with ŌURA to Expand Access to Comprehensive Contraceptive Care
06/05/2026
Facilitating Clinical Treatment for Women by Incorporating Comprehensive Data and Insights from ŌURA NEW YORK, May 06, 2026 (GLOBE NEWSWIRE) -- Twentyeight Health, the leading provider-led digital women’s healthcare [...]
Cristcot Appoints Rayna Herman as President of its Hydrocortisone Acetate Commercial Division
06/05/2026
Ms. Herman is a life sciences executive with extensive experience developing commercialization strategies and building commercial teams AUSTIN, Texas, May 06, 2026 (GLOBE NEWSWIRE) -- Cristcot, a clinical-stage [...]
Veru to Report Fiscal 2026 Second Quarter Financial Results on May 13th
06/05/2026
MIAMI, FL, May 06, 2026 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on developing innovative medicines for the treatment of cardiometabolic and inflammatory [...]
Oncotelic Therapeutics Announces Closing of a Strategic Monetization of Its CNS/Nasal Assets with Lunai Bioworks, Advancing Joint Development in Biodefense and Alzheimer’s Disease
06/05/2026
AGOURA HILLS, Calif., May 06, 2026 (GLOBE NEWSWIRE) -- via IBN -- Oncotelic Therapeutics, Inc. (OTCQB: OTLC) (“Oncotelic” or the “Company”), a late-stage clinical biopharmaceutical company focused on oncology and rare [...]
BioAdaptives, Inc. Launches MyndRenew™ to Complete the 24-Hour Brain Performance Cycle
06/05/2026
New Nighttime Supplement Targets What Happens — or Fails to Happen — While You Sleep LAS VEGAS, May 06, 2026 (GLOBE NEWSWIRE) -- via IBN — More than 1 in 3 American adults report insufficient sleep — a deficit that [...]
Where Executives Are Doubling Down on Their Companies’ Fortunes
06/05/2026
4 Stocks Under $15 Seeing Aggressive Insider Buying Activity DENVER, May 06, 2026 (GLOBE NEWSWIRE) -- 24/7 Market News and NeOnc Technology -- As market participants are sifting through data, one signal often cuts [...]
InflaRx Announces Pricing of $150 Million Underwritten Offering of Ordinary Shares
06/05/2026
Jena, Germany, May 06, 2026 (GLOBE NEWSWIRE) -- InflaRx N.V. (Nasdaq: IFRX) (the “Company”), a biopharmaceutical company pioneering anti-inflammatory therapeutics targeting the complement system, announced today the [...]
Ernexa Therapeutics Unveils Breakthrough Preclinical Results: ERNA-101 Achieves 100% Survival and Complete Tumor Elimination in Ovarian Cancer Models
06/05/2026
Landmark data positions ERNA-101 as a potential game-changing immunotherapy and a major catalyst for future clinical and shareholder value CAMBRIDGE, Mass., May 06, 2026 (GLOBE NEWSWIRE) -- Ernexa Therapeutics (Nasdaq: [...]
NEXGEL Appoints Brian Kieser and Kevin Harris from New Strategic Partner, Sequence LifeScience™, to Board of Directors
06/05/2026
Sequence LifeScience TM Led Financing to Close on Acquisition of Celularity with Strategic Investment of $5.5 Million LANGHORNE, Pa., May 06, 2026 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: “ [...]
CRISPR Therapeutics to Present at the Bank of America Securities 2026 Global Healthcare Conference
06/05/2026
ZUG, Switzerland and BOSTON, May 06, 2026 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP) today announced that members of its senior management team will present at the Bank of America Securities 2026 Global [...]
Orchestra BioMed Receives $20 Million Payment from Medtronic Under Previously Announced Financing Agreement
06/05/2026
Payment fulfills previously disclosed funding commitment of $20 million and supports planned completion of the BACKBEAT Global Pivotal Trial (“BACKBEAT Trial”) evaluating Atrioventricular Interval Modulation Therapy (“ [...]
Tekton Research Appoints Dr. Amit Vijapura as Central Nervous System Key Opinion Leader
06/05/2026
As CNS capabilities expand, Tekton adds seasoned leadership to accelerate growth and execution AUSTIN, Texas, May 06, 2026 (GLOBE NEWSWIRE) -- Tekton Research , a leading multi-site clinical trial organization with 25 [...]
Allogene Therapeutics to Report First Quarter Financial Results and Provide Business Update
06/05/2026
Conference Call and Webcast Scheduled for May 13, 2026 at 2 p.m. PT/5 p.m. ET SOUTH SAN FRANCISCO, Calif., May 06, 2026 (GLOBE NEWSWIRE) -- Allogene Therapeutics, Inc. (Nasdaq: ALLO), a clinical-stage biotechnology [...]
Actuate Therapeutics Announces Key Appointment of Industry Veteran to Board of Directors
06/05/2026
Martin Huber, MD brings deep expertise in oncology drug development, regulatory strategy, and commercialization of novel therapies CHICAGO and FORT WORTH, Texas, May 06, 2026 (GLOBE NEWSWIRE) -- Actuate Therapeutics, [...]
Becoming Independent Celebrates Outstanding Individuals and Partners at Second Annual Spotlight Awards
06/05/2026
Charles M. Schulz Museum, Morton & Bassett Spices, Alsco Uniforms among those honored SANTA ROSA, Calif., May 06, 2026 (GLOBE NEWSWIRE) -- Becoming Independent , a nonprofit supporting adults with disabilities live [...]
Annexon to Present at the Bank of America Securities Health Care Conference 2026
06/05/2026
BRISBANE, Calif., May 06, 2026 (GLOBE NEWSWIRE) -- Annexon, Inc. (Nasdaq: ANNX), a biopharmaceutical company advancing the next generation platform of targeted immunotherapies aimed at neuroinflammatory diseases that [...]
IN8bio to Showcase Next-Generation T Cell Engager Platform and New Clinical Data at Upcoming R&D Day and Medical Conferences
06/05/2026
NEW YORK, May 06, 2026 (GLOBE NEWSWIRE) -- IN8bio, Inc . (Nasdaq: INAB) (“IN8bio” or the “Company”), a clinical-stage biopharmaceutical company developing innovative gamma-delta (“γδ”) T cell therapies for cancer and [...]
Pliant Therapeutics to Participate in the RBC Capital Markets Global Healthcare Conference
06/05/2026
SOUTH SAN FRANCISCO, Calif., May 06, 2026 (GLOBE NEWSWIRE) -- Pliant Therapeutics, Inc. (Nasdaq: PLRX), a clinical-stage biotechnology company focused on the discovery and development of integrin-based therapeutics, [...]
Cannara complète l’acquisition de Medican Organic Inc.
06/05/2026
MONTRÉAL, 06 mai 2026 (GLOBE NEWSWIRE) -- Cannara Biotech Inc. (« Cannara », « la Société », « nous ») ( TSX : LOVE ) ( OTCQX : LOVFF ) ( FRA : 8CB0 ), producteur verticalement intégré de cannabis de qualité supérieure [...]

Pages